National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 14402 [2015-06269]
Download as PDF
<![CDATA[
14402
Federal Register / Vol. 80, No. 53 / Thursday, March 19, 2015 / Notices
Rmajette on DSK2VPTVN1PROD with NOTICES
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR14–247:
Pharmacogenetics, Pharmacoepigenetics and
Personalized Medicine in Children.
Date: April 16, 2015.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, 301–435–
1779, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Ocular Diseases Pathophysiology
and Therapeutic Approaches.
Date: April 16, 2015.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Alessandra C Rovescalli,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Rm. 5205
MSC7846, Bethesda, MD 20892, (301) 435–
1021, rovescaa@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
190: Detection of Pathogen Induced Cancer.
Date: April 17, 2015.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Rm. 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mai.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 13, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06268 Filed 3–18–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Food and Drug Administration
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
[Docket No. FDA–2015–N–0620]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications,
contract proposal, and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications or
contract proposal, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Research in HIV/HLB Diseases.
Date: April 13, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Avenue NW., Washington, DC
20036.
Contact Person: Stephanie L Constant,
Ph.D. Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784 constantsl@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Improving Red Blood Cells for Transfusion.
Date: April 13, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7198, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Kristin Goltry, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7198, Bethesda, MD 20892, 301–435–0297,
goltrykl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 13, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06269 Filed 3–18–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
15:18 Mar 18, 2015
Jkt 235001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
An Interactive Discussion on the
Clinical Considerations of Risk in the
Postmarket Environment; Public
Workshop; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled ‘‘Clinical Considerations of Risk
in the Postmarket Environment.’’ The
purpose of this workshop is to provide
a forum for an interactive discussion on
assessing changes in medical device risk
as quality and safety situations arise in
the postmarket setting when a patient,
operator, or member of the public uses
the device. FDA is interested in
obtaining input from stakeholders about
assessing risk postmarket when new
hazards develop in the postmarket
setting that were not present or not
known at the time of clearance or
approval or hazards were anticipated,
but harm occurs at an unexpected rate
or in unexpected populations or use
environments. Comments and
suggestions generated through this
workshop will facilitate the assessment
of risk in postmarket quality and safety
situations.
Date and Time: The public workshop
will be held on April 21, 2015, from
8:30 a.m. to 5 p.m.
Location: The public workshop will
be held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Building
31 Conference Center, the Great Room
(Rm. 1503), Silver Spring, MD 20993–
0002. Entrance for the public meeting
participants (non-FDA employees) is
through Building 1 where routine
security check procedures will be
performed. For parking and security
information, please refer to: https://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
Contact Person: Jean M. Cooper,
Center for Devices and Radiological
Health, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 66,
Rm. 5540, Silver Spring, MD 20993,
301–796–6141, email: Jean.Cooper@
fda.hhs.gov.
Registration: Registration is free and
available on a first-come, first-served
basis. Persons interested in attending
this public workshop must register
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 80, Number 53 (Thursday, March 19, 2015)]
[Notices]
[Page 14402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06269]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications, contract proposal, and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications or
contract proposal, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Clinical Research in HIV/HLB Diseases.
Date: April 13, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Dupont Circle Hotel, 1500 New Hampshire Avenue NW.,
Washington, DC 20036.
Contact Person: Stephanie L Constant, Ph.D. Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7189, Bethesda, MD
20892, 301-443-8784 constantsl@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Improving Red Blood Cells for Transfusion.
Date: April 13, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6701 Rockledge Drive, Room
7198, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kristin Goltry, Ph.D. Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7198, Bethesda, MD 20892, 301-
435-0297, goltrykl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: March 13, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06269 Filed 3-18-15; 8:45 am]
BILLING CODE 4140-01-P
